Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

Published:2024-03 Issue:1 Volume:35 Page:102137
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Hall Jeremy,Zhang Zhuoran,Bhattacharya Supriyo,Wang Dongfang,Alcantara Marice,Liang Yong,Swiderski Piotr,Forman Stephen,Kwak Larry,Vaidehi Nagarajan,Kortylewski Marcin

Funder

National Cancer Institute

Publisher

Elsevier BV

Reference62 articles.

1. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment;Yu;Nat. Rev. Immunol.,2007

2. STAT proteins in cancer: orchestration of metabolism;Li;Nat. Rev. Cancer,2023

3. JAK-STAT core cancer pathway: An integrative cancer interactome analysis;Erdogan;J. Cell. Mol. Med.,2022

4. The JAK-STAT pathway at 30: Much learned, much more to do;Philips;Cell,2022

5. Targeting the IL-6/JAK/STAT3 signalling axis in cancer;Johnson;Nat. Rev. Clin. Oncol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the STAT3 pathway with STAT3 degraders;Trends in Pharmacological Sciences;2024-09

2. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09

3. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma;Cancer Letters;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP